| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |